The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.
Kox
C
C
Department of Pediatric Oncology, Hematology and Immunology, Angelika Lautenschläger Children's Hospital, University of Heidelberg, Heidelberg, Germany.
Zimmermann
M
M
Stanulla
M
M
Leible
S
S
Schrappe
M
M
Ludwig
W-D
WD
Koehler
R
R
Tolle
G
G
Bandapalli
O R
OR
Breit
S
S
Muckenthaler
M U
MU
Kulozik
A E
AE